Resolve Biosciences
John Stark has a strong background in the biotechnology industry, with a focus on executive leadership and sales. John most recently served as the Chief Executive Officer at Quantum-Si from November 2020 to February 2022. Prior to that, they held the same role at Celsee, Inc. from January 2018 to April 2020, where they successfully oversaw the acquisition of the company by Bio-Rad Laboratories. Before that, they were the Senior Vice President at Fluidigm Corporation from October 2015 to October 2017. John also served as the Vice President Clinical and Applied Markets at Life Technologies from October 2011 to October 2015, and as the Senior Director of Sales at Pacific Biosciences from September 2009 to September 2011. Their early career experience includes a role as the District Manager, East Region Industrial Sales at Affymetrix from April 2001 to January 2007.
John Stark attended Grand Ledge from 1989 to 1992. John did not receive a degree or specialize in a particular field during this time. Later, from 1998 to 1999, they pursued an M.S. degree in Bioengineering at Arizona State University.
This person is not in any offices
Resolve Biosciences
Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.